TROP2
Clinical trials for TROP2 explained in plain language.
Never miss a new study
Get alerted when new TROP2 trials appear
Sign up with your email to follow new studies for TROP2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer patients with brain tumors: Real-World drug study launches
Disease control Recruiting nowThis study looks at how well a drug called Trop-2 ADC (sacituzumab govitecan) works for breast cancer patients whose cancer has spread to the brain. Researchers will track 100 patients from multiple hospitals to see if the drug shrinks brain tumors and how safe it is. The goal is…
Matched conditions: TROP2
Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 16, 2026 22:32 UTC
-
New scan may predict lung cancer drug response
Knowledge-focused Recruiting nowThis study is testing whether a special PET scan can predict how well a targeted cancer drug works in people with advanced lung cancer. About 50 adults with metastatic non-small cell lung cancer will get the scan before and during treatment. The goal is to see if changes in the s…
Matched conditions: TROP2
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC